List of Konvomep drug patents

Konvomep is owned by Azurity.

Konvomep contains Omeprazole; Sodium Bicarbonate.

Konvomep has a total of 2 drug patents out of which 0 drug patents have expired.

Konvomep was authorised for market use on 30 August, 2022.

Konvomep is available in for suspension;oral dosage forms.

The generics of Konvomep are possible to be released after 16 July, 2039.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10751333 AZURITY Compositions and kits for omeprazole suspension
Jul, 2039

(16 years from now)

US11103492 AZURITY Compositions and kits for omeprazole suspension
Jul, 2039

(16 years from now)

Do you want to check out KONVOMEP patents from before 2022?

Drugs and Companies using OMEPRAZOLE; SODIUM BICARBONATE ingredient

Market Authorisation Date: 30 August, 2022

Treatment: NA

Dosage: FOR SUSPENSION;ORAL

More Information on Dosage

KONVOMEP family patents

6

United States

1

China

1

Canada

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in